LIBOCE-TRIO-2
Type:
Tablet
Pack:
10x10
Packing:
Blister Pack
Category:
DIABETOLOGY
Price:
₹1,900.00
Contact Us to Purchase
Composition Details
Voglibose 0.2mg + Glimepiride 2mg + Metformin 500mg SR
Description & Effects
LIBOCE-TRIO-2 is a comprehensive oral antidiabetic medication containing a powerful combination of Glimepiride, Metformin, and Voglibose. This triple-drug formulation is used in the management of type 2 diabetes mellitus, particularly in patients whose blood sugar levels are not adequately controlled through diet, exercise, or dual therapy alone.Glimepiride is a sulfonylurea that works by stimulating the pancreas to produce more insulin, thereby lowering blood sugar levels. Metformin, a biguanide, helps by reducing the liver’s glucose production, decreasing the absorption of glucose from the intestines, and improving the body’s response to insulin. Voglibose is an alpha-glucosidase inhibitor that delays carbohydrate digestion and absorption in the intestines, effectively controlling postprandial (after-meal) blood sugar spikes.
Together, these three agents offer a complementary mechanism of action that targets multiple pathways involved in glucose regulation. LIBOCE-TRIO-2 helps manage both fasting and post-meal blood sugar levels, improving overall glycemic control and reducing the risk of diabetes-related complications.
This medicine is usually taken just before meals to maximize its effectiveness. It should be used under medical supervision along with lifestyle modifications such as a healthy diet and regular physical activity. Regular blood sugar monitoring is essential to ensure optimal results and safety.
